Metraipolis › archive › dc_709d48cbdc4f

Long-term safety of intravenous human umbilical cord blood-derived mesenchymal stem cell therapy in rheumatoid arthritis: a 5-year follow-up study — Europe PMC PMID:42556324

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42556324
DOI
10.1093/stcltm/szag062
License (as archived)
solo-consultazione
Archived
2026-10-18T12:27:44.527Z
SHA-256 of the archived text
9c434487d71dc5c30e8f715bd620417d4910365e59bcd85611b6f1f2ad165347
Stable URL of this page
https://metraipolis.com/documento/dc_709d48cbdc4f

How to cite

Long-term safety of intravenous human umbilical cord blood-derived mesenchymal stem cell therapy in rheumatoid arthritis: a 5-year follow-up study — Europe PMC PMID:42556324 — Europe PMC (en), https://europepmc.org/article/MED/42556324 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_709d48cbdc4f (Metraipolis archive dc_709d48cbdc4f, sha256 9c434487d71dc5c30e8f715bd620417d4910365e59bcd85611b6f1f2ad165347)
BibTeX
@misc{dc709d48cbdc4f,
  title = {Long-term safety of intravenous human umbilical cord blood-derived mesenchymal stem cell therapy in rheumatoid arthritis: a 5-year follow-up study — Europe PMC PMID:42556324},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42556324},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_709d48cbdc4f; sha256 9c434487d71dc5c30e8f715bd620417d4910365e59bcd85611b6f1f2ad165347},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42556324. Agents can read the archived copy with the MCP tool read_document.